Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/25/2026
- S&P 500 ends marginally lower as investors focus on US-Iran war
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oil gains on little sign of progress in US-Iran talks
- S&P 500 history shows strong gains across Fed hiking cycles: BCA
- JPMorgan upgrades CoreWeave on stronger compute pricing
- Bloom Energy falls as Oracle invokes force majeure on AI project
- Akamai signs $11.6B deal with Anthropic, up to $20B potential
- Oracle triggers force majeure on massive 'Project Jupiter' data center
- Oracle Sends Force Majeure Notice Over New Mexico Data Center - Bloomberg
- US and Iran discuss phased deal to reopen Hormuz and end US blockade, sources say
Sucampo Pharma (SCMP) Tops Q4 EPS by 20c, Names CFO
March 8, 2017 6:41 AM ESTSucampo Pharma (NASDAQ: SCMP) reported Q4 EPS of $0.68, $0.20 better than the analyst estimate of $0.48. Revenue for the quarter came in at $73 million versus the consensus estimate of $66 million.
Sucampo today reiterated its guidance for the full year ending December 31, 2017.
Additionally, today Sucampo... More
